Bavarian Nordic A/S is a biotechnology and pharmaceutical company headquartered in Hellerup, Denmark. The company primarily focuses on the development, manufacturing, and commercialization of vaccines... Bavarian Nordic A/S is a biotechnology and pharmaceutical company headquartered in Hellerup, Denmark. The company primarily focuses on the development, manufacturing, and commercialization of vaccines for infectious diseases and immunotherapy treatments for cancer. Notably, Bavarian Nordic is recognized for its breakthrough work in developing vaccines against smallpox, Ebola, and other emerging infectious diseases, contributing significantly to global public health initiatives. With a robust product pipeline and a commitment to research and innovation, Bavarian Nordic plays a crucial role in the biotechnology sector, impacting both healthcare and national security through its vaccine offerings. The company's collaborations with governments, health organizations, and fellow biotech firms underscore its importance in the pharmaceutical landscape as a prominent developer of next-generation vaccines.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Energy Management data not yet covered for Bavarian Nordic

We have not yet reviewed Bavarian Nordic's disclosures for Energy Management data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Bavarian Nordic's data?

Start your 30-day free trial to request a data review for Bavarian Nordic.

Start Free Trial

Legal Center Contact Us